The SURMOUNT-1 trial found that participants achieved average weight reductions of 16%, 19.5%, and about 21% on the 5 mg, 10 mg, and 15 mg doses, respectively, over 72 weeks
At Invigue, we tailor your treatment to your unique health profile, monitor your progress regularly, and adjust it as needed to achieve safe and sustainable results
SeekPeptides members get access to detailed side effect management protocols, interaction databases, and personalized support from experienced researchers who understand the real-world challenges of GLP-1 therapy
However, for elderly adults with multiple chronic diseases and irreversible functional impairments, treatment priorities should shift towards improving quality of life, preventing disease-related symptoms or acute complications, and addressing geriatric syndromes
Some may lower dose
It is given once in a week for 6 weeks